Literature DB >> 5294334

[Nephropathy in a case of essential osteolysis. Electronic and optic microscopic studies].

F Chatelanat, G Simon.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 5294334

Source DB:  PubMed          Journal:  Virchows Arch Pathol Anat Physiol Klin Med        ISSN: 0376-0081


× No keyword cloud information.
  8 in total

1.  [Contribution of electron microscopy to the study of the mechanism of experimental arterial hypertension of renal origin in rats; lesions of the renal arteries].

Authors:  P Y HATT; A DONTCHEFF
Journal:  Arch Mal Coeur Vaiss       Date:  1959-05

2.  OSTEOARTICULAR CHANGES IN A CASE OF ESSENTIAL OSTEOLYSIS; AN ANATOMICAL AND RADIOLOGICAL STUDY.

Authors:  R LAGIER; E RUTISHAUSER
Journal:  J Bone Joint Surg Br       Date:  1965-05

3.  [Essential acro-osteolysis complicated by renal insufficiency with fatal evolution].

Authors:  J MARIE; B LEVEQUE; G LYON; M BEBE; J M WATCHI
Journal:  Presse Med       Date:  1963-01-30       Impact factor: 1.228

4.  [Essential osteolysis and nephritis].

Authors:  D MAHOUDEAU; J DUBRISAY; B ELISSALDE; C SRAER
Journal:  Bull Mem Soc Med Hop Paris       Date:  1961 Feb 3-Mar 24

5.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

6.  [A case of essential osteolysis].

Authors:  M NEYROUD; J BAUMGARTNER; A LENOIR
Journal:  Helv Paediatr Acta       Date:  1956-05

7.  The clinical picture of primary hyperparathyroidism as illustrated by four cases.

Authors:  K SCHMITH; V FABER
Journal:  Acta Endocrinol (Copenh)       Date:  1952-04

8.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

  8 in total
  1 in total

1.  Case report 401: Idiopathic carpal/tarsal osteolysis (ICTO) associated with nephropathy.

Authors:  G F Vichi; F Falcini; M Pierattelli; R Jenuso; M Ceruso
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.